BRIEF-GSK CEO still expects respiratory to return to growth in 2016

miércoles 28 de octubre de 2015 08:40 GYT
 

Oct 28 (Reuters) - GlaxoSmithKline Plc CEO Andrew Witty told reporters:

* still expects respiratory to return to growth in 2016

* expects emerging markets to improve in q4 and sees decent growth next year

* says pricing a big focus in u.s., shows need to have business strategy not totally dependent on price

* seeing disruption in some emerging markets, including brazil, russia, mideast

* q3 progress means very optimistic will get to consumer margins of at least 20 percent Further company coverage: (Reporting by UK bureau)